Table 3.
Intra-operative data, blood product use, and outcome parameters between groups.
| CTR | TRT | p Value | |
|---|---|---|---|
| Perfusion time* | 131 ± 25 | 145 ± 28 | NS |
| Clamp time* | 87 ± 20 | 97 ± 20 | NS |
| Operative blood product use | |||
| PRBC | |||
| 0 | 12 (80%) | 10 (67%) | NS |
| 1 or more | 3 (20%) | 5 (33%) | |
| PLT | |||
| 0 | 11 (73%) | 13 (87%) | NS |
| 1 or more | 4 (27%) | 2 (13%) | |
| FFP | |||
| 0 | 15 (100%) | 14 (93%) | NS |
| 1 or more | — | 1 (7%) | |
| CRYO | |||
| 0 | 15 (100%) | 15 (100%) | NS |
| 1 or more | — | — | |
| 48-hour post-operative blood product usage | |||
| PRBC | |||
| 0 | 14 (93%) | 14 (93%) | NS |
| 1 or more | 1 (7%) | 1 (7%) | |
| PLT | |||
| 0 | 12 (80%) | 14 (93%) | NS |
| 1 or more | 3 (20%) | 1 (7%) | |
| FFP | |||
| 0 | 14 (93%) | 13 (87%) | NS |
| 1 or more | 1 (7%) | 2 (13%) | |
| CRYO | |||
| 0 | 15 (100%) | 15 (100%) | NS |
| 1 or more | — | — | |
| Outcome parameters | |||
| 24-hour MT output | 562 ± 161 | 509 ± 33 | NS |
| 48-hour MT output | 257 ± 144 | 251 ± 174 | NS |
| Ventilation time | |||
| ≤6 hours | 8 (53%) | 6 (40%) | NS |
| >6 hours | 7 (47%) | 9 (60%) | |
| ICU length of stay | |||
| ≤1 day | 3 (20%) | 5 (33%) | NS |
| 1–2 days | 7 (47%) | 6 (40%) | |
| >2 days | 5 (33%) | 4 (27%) | |
| Hospital length of stay | |||
| ≤4 days | 7 (47%) | 6 (40%) | NS |
| >4 days | 8 (53%) | 9 (60%) | |
*
Comparison between groups was based on 12 on-pump CABG cases in the CTR group and 13 on-pump cases in the TRT group.
NS, not significant; PRBC, packed red blood cells; PLT, platelets; FFP, fresh frozen plasma; CRYO, cryoprecipitate; MT, mediastinal tube.